Andrew Hughes
Director/Board Member at CellCentric Ltd.
Andrew Hughes active positions
Companies | Position | Start | End |
---|---|---|---|
Manchester Cancer Research Centre | Corporate Officer/Principal | - | - |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 2022-04-05 | - |
Career history of Andrew Hughes
Former positions of Andrew Hughes
Companies | Position | Start | End |
---|---|---|---|
PCI BIOTECH HOLDING ASA | Director/Board Member | 2018-04-30 | 2023-05-24 |
Independent Dir/Board Member | 2018-04-30 | 2023-05-24 | |
The University of Manchester | Corporate Officer/Principal | 2005-12-31 | - |
AstraZeneca AS | Corporate Officer/Principal | - | - |
Statistics
International
Norway | 3 |
United Kingdom | 3 |
Israel | 2 |
Operational
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Independent Dir/Board Member | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
PCI BIOTECH HOLDING ASA | Health Technology |
Private companies | 3 |
---|---|
AstraZeneca AS | |
Manchester Cancer Research Centre | |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Andrew Hughes
- Experience